FREMONT, Calif.--(BUSINESS WIRE)--Dr. Philippe Henri Marco has been named President and Chief Executive Officer of Palmaz Scientific, Inc. Palmaz Scientific Chairman Julio Palmaz, MD, made the announcement today. Dr. Marco replaces former CEO Steven Solomon who resigned to pursue other opportunities.
Dr. Marco, 51, comes to Palmaz Scientific from Chansu Consulting, LLC in Fremont, where he was a general partner, providing strategic regulatory, clinical, quality assurance, R&D and business development support for early stage ventures, as well as operational strategy for several cardiovascular device companies. He has more than 20 years of leadership experience in medical device ventures, including in-depth knowledge of the interventional cardiac and endovascular fields as well as experience in product development, manufacturing operations, regulatory strategy, clinical trial coordination and management, marketing and sales training.
“Dr. Marco is a perfect fit for us,” Dr. Palmaz said. “His interventional cardiac and endovascular medical industry background is right in line with our company vision of creating a technology platform with the promise to bring to market a revolutionary generation of stents and other implantable devices that could change the practice of medicine. He has an excellent track record in taking medical devices through regulatory approvals to market.”
“In the past 15 months,” Dr. Palmaz said, “under Philippe’s guidance, Chansu Consulting achieved a full FDA IDE (Investigational Device Exemption) approval, two CE marks and a First-in-Human study approval, as well as submitting a PMA (Pre-Market Approval) and two 510k (Pre-Market Notification) filings with the Food & Drug Administration. That sort of experience is vital for Palmaz Scientific at this stage in our development.”
Dr. Palmaz began Palmaz Scientific in 2008 with a vision to create a technology platform with the promise to bring to market a revolutionary generation of stents and other implantable devices that could change the practice of medicine. To that end, the company has worked to develop a potentially game-changing nanotechnology application, based on Plasma Vapor Deposition (PVD), to produce more precise implantable medical devices that are extremely thin, yet structurally very robust. The technology is supported by more than 250 issued patents with some 130-plus additional active patent filings in process.
“This company has an extraordinary opportunity to fundamentally change the way medical device development is approached,” Dr. Marco said, “and I am excited to come in at this stage and to have the opportunity to work side by side with Dr. Julio Palmaz, who is one of the truly great innovators in medical history. We will take the offensive, by designing, testing and producing our own devices, breaking through the current conventional approach to medical device manufacturing. For example, we believe that we can create superior devices to those currently marketed in order to treat patients with peripheral artery disease, intra-cranial aneurysms or structural heart disease, addressing substantial unmet medical needs for both patients and clinicians.”
Dr. Palmaz said, “Our team at Palmaz Scientific, through our PVD application, is now able to consistently and efficiently produce high performance super alloys which are ideal for creating state-of-the-art medical devices. We have advanced the technology beyond the limits imposed by current materials and methods and will now seek full regulatory approval in the United States and international markets. I appreciate the efforts of Steve Solomon who has been instrumental in bringing us to this point of development.”
About Palmaz Scientific
Palmaz Scientific, Inc. was founded to pursue the research, development and commercialization of advanced metallurgical surface nanotechnologies for the manufacture of implantable medical devices. The Palmaz technology uses plasma vapor deposition processes to deposit layers of atoms on a substrate to produce very strong, high purity metals which are then fabricated into low profile implantable medical devices for many applications including stent platforms, angioplasty devices, and drug delivery platforms. In addition, Palmaz Scientific is developing advanced surface engineering to accelerate the healing process of cells on metals used in implantable medical devices. Visit www.palmazscientific.com for more information.
